miRNA to Guide Appropriate Intervention of Small Testis Masses
NCT07852871
Summary
This study aims to determine, for the first time, if miRNA-371a-3p can be used as an accurate biomarker to identify which small (≤ 2cm) testicular masses are malignant and aid in clinical decision-making to offer surgery or surveillance. We propose a retrospective exploration of banked serum, plasma and semen specimens of men with small testis masses and a prospective biomarker-based intervention trial to validate miR-371a-3p performance.
Eligibility
Inclusion Criteria: * • Small testicular mass/masses ≤ 2cm * Patients with serum tumour marker elevation are eligible only if they are considered for surgical treatment, or if markers are felt to be falsely elevated by the physician team * If the patient previously had chemotherapy, the mass must first have appeared only after the treatment completed * The patient is at least 18 years of age * Ability to understand and comply with the requirements of the study * Ability to understand and willingness to sign a written informed consent Exclusion Criteria: * • Patients with testicular tumours \> 2 cm * Metastatic disease * Patients in reduced general condition, with uncontrolled intercurrent illnesses, or with life-threatening disease * Patients with psychiatric illnesses that would limit compliance with study requirements * Clinical decision is made by the multidisciplinary team that patient is not suitable for surveillance
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07852871